+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular And Soft Tissue Repair Patches Market by Application, by Raw Material, and by Region - Global Forecast to 2023-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717244
The cardiovascular and soft tissue repair patches market size is estimated to be USD 3,952.4 million in 2022 and is expected to witness a CAGR of 8.71% during the forecast period 2023-2033. Technology improvements and rising frequency of congenital heart diseases including atrial and ventricular septal defects are projected to drive the market growth in near future. Furthermore, increasing demand of public-private partnerships are being strengthened across a number of regional markets rising incidence of hernias, such as inguinal hernias, umbilical hernias, congenital diaphragmatic hernias, and ventral hernias are other factors supporting the market growth. However, high cost of surgical process and post therapeutic issues are predicted to limit market.

Rising incidence of hernias, such as inguinal hernias, umbilical hernias, congenital diaphragmatic hernias, and ventral hernias is expected to fuel the market growth during the forecast period. According to research, abdominal wall hernias are the most frequent hernias, with incidence rate of 1.7% for people of all ages and 4% for people over the age of 45. The majority of cases (75%) of abdominal wall hernias are inguinal hernias, which are the most often diagnosed type. In the United States, there were 28 inguinal hernia repairs performed for every 100,000 people, compared to 10 in the United Kingdom.

Increasing demand of public-private partnerships are being strengthened across a number of regional markets is predicted to propel the market during projected period. For instance, governments are launching plans to enhance cardiac treatment alternatives' accessibility and affordability, which is projected to drive growth. For instance, the development of regenerative heart repair patches by Osaka Medical College and Teijin Limited and Fukui Warp Knitting Co. Ltd. received assistance and recognition from the Japanese government. Governments are starting to support and encourage partnerships between medical and industrial players.

Segmentation

By Application

The market is categorized into vascular repair & reconstruction, cardiac repair, dural repair, soft tissue repair, and pericardial repair. In 2022, the soft tissue repair segment accounted for the highest revenue share due to the rapidly rising incidence rate of hernias, such as congenital diaphragmatic hernias, ventral hernias, inguinal hernias, umbilical hernias, and others, and escalating demand for tissue repair patches in therapeutic operations. The segment is expanding as a result of an increase in inguinal hernia repairs. However, the cardiac repair segment is expected to experience the fastest growth rate in the market for cardiovascular and soft tissue repair patches over the next years. The demand for cardiac patches is being driven up by the significant increase of congenital heart disorders among children worldwide. According to research, the atrial septal defect, which affects 10% of children and 30% of adults with congenital heart disease, is the third most prevalent congenital heart condition. Two interconnected cardiac patches that cover both the right and left atrial sides are permanently inserted into the hole to close the atrial septal defect.

By Raw Material

The market is categorized into biomaterial and tissue engineered material, ePTFE, and others. In the global market, the ePTFE segment accounted for the largest revenue share in 2022 owing to its various advantages including its high durability, high tensile strength, and ease of availability. In addition, ePTFE is frequently used in the production of medical accessories including face masks, dressings, drainage bags, ostomy bags, urine bags, and enclosures for medical devices. However, it is predicted that during the future years, the market for cardiovascular and soft tissue repair patches would expand at the quickest rate for biomaterial and tissue-engineered materials. Bovine pericardium is becoming more popular is the most frequently used raw material in the production of cardiovascular and soft tissue repair patches. Bovine pericardium has a number of physical and chemical qualities that are encouraging its use. Additionally, benefits related to bovine pericardium, such as its simplicity in the human body and low risk of problems following surgery, are propelling the market. The high structural protein composition of the bovine pericardium gives it improved elasticity and conformance that is suitable for a variety of anatomical conditions. These patches can be readily modified to fit specific configurations and sizes.

Regional Markets

In 2022, North America region accounted for the highest revenue in the cardiovascular and soft tissue repair patches market and is expected to maintain its dominance during the forecast period. This is attributed to rapidly evolving lifestyles, growing prevalence of substance misuse and obesity, increasing rates of alcohol consumption and smoking, rising rates of hernia problems, and surge in the number of heart diseases. The market for cardiovascular and soft tissue repair patches is being driven by rising disposable income, improving healthcare infrastructure, easy access to novel products and technology, and presence of many major players in North America. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increasing prevalence of heart diseases, developing healthcare infrastructure, growing disposable income, and rising healthcare awareness in this region. The expansion is being fueled by an increase in knowledge about early diagnosis and detection of congenital heart disorders and timely treatment plans like cardiac patch implantation. According to World Health Organization projections, between 2010 and 2030, the yearly incidence rate of cardiovascular diseases is predicted to increase by 50%, creating growth opportunities for the Asia Pacific market for cardiovascular and soft tissue repair patches.

Competitor Insights

Some of the key players operating in the cardiovascular and soft tissue repair patches market are Southern Lights Biomaterials, B. Braun, Baxter, Abbott, LeMaitre Vascular Inc., Gunze Limited, Edwards Life Sciences Corporation, Atriummed, Perouse Medical, Glycar SA Pty Ltd., LabCor, Maverick Bioscience, Cryolife, Inc., CorMatrix, Terumo Medical Corporation, Admedus, Bard Peripheral Vascular Inc., Neovasc, W.L. Gore & Associates, Inc., Novomedics, TEI Biosciences Inc., and Integra LifeSciences Corporation.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

In October 2022, Biostage, Inc. revealed that a US patent had been granted to cover the company's technology's expansion from hollow tubes to patches for organ and tissue healing.

In order to enhance their portfolio of PerQseal Vessel Closure Devices, Vivasure Medical declared series D financing in May 2022.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including application and raw material from 2022 to 2033.

Segmentation: Cardiovascular And Soft Tissue Repair Patches Market Report 2022 - 2033

Application (Revenue, USD Million), 2022 - 2033

Vascular Repair & Reconstruction

  • Anomalous connection of the pulmonary veins
  • Carotid endarterectomy
  • Reconstruction of portal and superior mesenteric veins
  • Transposition of the great vessels
  • Other Vascular repair and reconstruction

Cardiac Repair

  • Common Atrium
  • Atrial septal defect
  • Tetralogy of Fallot
  • Right ventricular outflow tract Reconstruction
  • Ventricular septal defect
  • Suture bleeding
  • Defects of the endocardial cushion
  • Dural Repair

Soft Tissue Repair

  • Defects of the thoracic wall
  • Defects of the abdominal wall
  • Hernias
  • Gastric binding
  • Pericardial Repair

Raw Material (Revenue, USD Million), 2022 - 2033

  • Biomaterial and Tissue Engineered Material
  • ePTFE
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Cardiovascular And Soft Tissue Repair Patches

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Cardiovascular And Soft Tissue Repair Patches Market

7. Market Analysis by Application
7.1. Vascular Repair & Reconstruction
7.1.1. Vascular Repair & Reconstruction Market Forecast, 2022-2033 (USD Million)
7.1.1.1. Anomalous connection of the pulmonary veins
7.1.1.1.1. Anomalous connection of the pulmonary veins Market Forecast, 2022-2033 (USD Million)
7.1.1.2. Carotid endarterectomy
7.1.1.2.1. Carotid endarterectomy Market Forecast, 2022-2033 (USD Million)
7.1.1.3. Reconstruction of portal and superior mesenteric veins
7.1.1.3.1. Reconstruction of portal and superior mesenteric veins Market Forecast, 2022-2033 (USD Million)
7.1.1.4. Transposition of the great vessels
7.1.1.4.1. Transposition of the great vessels Market Forecast, 2022-2033 (USD Million)
7.1.1.5. Other Vascular repair and reconstruction
7.1.1.5.1. Other Vascular repair and reconstruction Market Forecast, 2022-2033 (USD Million)
7.2. Cardiac Repair
7.2.1. Cardiac Repair Market Forecast, 2022-2033 (USD Million)
7.2.1.1. Common Atrium
7.2.1.1.1. Common Atrium Market Forecast, 2022-2033 (USD Million)
7.2.1.2. Atrial septal defect
7.2.1.2.1. Atrial septal defect Market Forecast, 2022-2033 (USD Million)
7.2.1.3. Tetralogy of Fallot
7.2.1.3.1. Tetralogy of Fallot Market Forecast, 2022-2033 (USD Million)
7.2.1.4. Right ventricular outflow tract Reconstruction
7.2.1.4.1. Right ventricular outflow tract Reconstruction Market Forecast, 2022-2033 (USD Million)
7.2.1.5. Ventricular septal defect
7.2.1.5.1. Ventricular septal defect Market Forecast, 2022-2033 (USD Million)
7.2.1.6. Defects of the endocardial cushion
7.2.1.6.1. Defects of the endocardial cushion Market Forecast, 2022-2033 (USD Million)
7.2.1.7. Suture bleeding
7.2.1.7.1. Suture bleeding Market Forecast, 2022-2033 (USD Million)
7.3. Dural Repair
7.3.1. Dural Repair Market Forecast, 2022-2033 (USD Million)
7.4. Soft Tissue Repair
7.4.1. Soft Tissue Repair Market Forecast, 2022-2033 (USD Million)
7.4.1.1. Defects of the thoracic wall
7.4.1.1.1. Defects of the thoracic wall Market Forecast, 2022-2033 (USD Million)
7.4.1.2. Defects of the abdominal wall
7.4.1.2.1. Defects of the abdominal wall Market Forecast, 2022-2033 (USD Million)
7.4.1.3. Hernias
7.4.1.3.1. Hernias veins Market Forecast, 2022-2033 (USD Million)
7.4.1.4. Gastric binding
7.4.1.4.1. Gastric binding Market Forecast, 2022-2033 (USD Million)
7.5. Pericardial Repair
7.5.1. Pericardial Repair Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Raw Material
8.1. Biomaterial and Tissue Engineered Material
8.1.1. Biomaterial and Tissue Engineered Material Market Forecast, 2022-2033 (USD Million)
8.2. ePTFE
8.2.1. ePTFE Market Forecast, 2022-2033 (USD Million)
8.3. Others
8.3.1. Others Market Forecast, 2022-2033 (USD Million)

9. Regional Market Analysis
9.1. Regional Market Trends

10. North America Cardiovascular And Soft Tissue Repair Patches Market
10.1. North America Cardiovascular And Soft Tissue Repair Patches Market
10.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
10.2. U.S. Cardiovascular And Soft Tissue Repair Patches Market
10.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
10.3. Canada Cardiovascular And Soft Tissue Repair Patches Market
10.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)

11. Europe Cardiovascular And Soft Tissue Repair Patches Market
11.1. Europe Cardiovascular And Soft Tissue Repair Patches Market
11.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
11.2. Germany Cardiovascular And Soft Tissue Repair Patches Market
11.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
11.3. UK Cardiovascular And Soft Tissue Repair Patches Market
11.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
11.4. France Cardiovascular And Soft Tissue Repair Patches Market
11.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
11.5. Spain Cardiovascular And Soft Tissue Repair Patches Market
11.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
11.6. Italy Cardiovascular And Soft Tissue Repair Patches Market
11.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
11.7. Rest of Europe Cardiovascular And Soft Tissue Repair Patches Market
11.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)

12. Asia Pacific Cardiovascular And Soft Tissue Repair Patches Market
12.1. Asia Pacific Cardiovascular And Soft Tissue Repair Patches Market
12.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
12.2. Japan Cardiovascular And Soft Tissue Repair Patches Market
12.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
12.3. China Cardiovascular And Soft Tissue Repair Patches Market
12.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
12.4. India Cardiovascular And Soft Tissue Repair Patches Market
12.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
12.5. South Korea Cardiovascular And Soft Tissue Repair Patches Market
12.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by Device, 2022-2033 (USD Million)
12.6. Australia Cardiovascular And Soft Tissue Repair Patches Market
12.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
12.6.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.6.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
12.7. Rest of Asia Pacific Cardiovascular And Soft Tissue Repair Patches Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.7.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.7.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)

13. Latin America Cardiovascular And Soft Tissue Repair Patches Market
13.1. Latin America Cardiovascular And Soft Tissue Repair Patches Market
13.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
13.2. Brazil Cardiovascular And Soft Tissue Repair Patches Market
13.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
13.3. Mexico Cardiovascular And Soft Tissue Repair Patches Market
13.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
13.4. Argentina Cardiovascular And Soft Tissue Repair Patches Market
13.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
13.5. Rest of Latin America Cardiovascular And Soft Tissue Repair Patches Market
13.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.5.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.5.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)

14. MEA Cardiovascular And Soft Tissue Repair Patches Market
14.1. MEA Cardiovascular And Soft Tissue Repair Patches Market
14.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
14.1.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.1.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
14.2. GCC Cardiovascular And Soft Tissue Repair Patches Market
14.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
14.2.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.2.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
14.3. South Africa Cardiovascular And Soft Tissue Repair Patches Market
14.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
14.3.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.3.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)
14.4. Rest of MEA Cardiovascular And Soft Tissue Repair Patches Market
14.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
14.4.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.4.1.2. Market Size and Forecast by Raw Material, 2022-2033 (USD Million)

15. Competitor Analysis
15.1. Market Share Analysis, 2022
15.2. Major Recent Developments, 2019-2022

16. Company Profiles
16.1. Southern Lights Biomaterials
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financials
16.1.4. Application Benchmarking
16.1.5. Recent Developments
16.2. B. Braun
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financials
16.2.4. Application Benchmarking
16.2.5. Recent Developments
16.3. Baxter
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financials
16.3.4. Application Benchmarking
16.3.5. Recent Developments
16.4. Baxter
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financials
16.4.4. Application Benchmarking
16.4.5. Recent Developments
16.5. Abbott
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financials
16.5.4. Application Benchmarking
16.5.5. Recent Developments
16.6. LeMaitre Vascular Inc.
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financials
16.6.4. Application Benchmarking
16.6.5. Recent Developments
16.7. Gunze Limited
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financials
16.7.4. Application Benchmarking
16.7.5. Recent Developments
16.8. Edwards Life Sciences Corporation
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financials
16.8.4. Application Benchmarking
16.8.5. Recent Developments
16.9. Atriummed
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financials
16.9.4. Application Benchmarking
16.9.5. Recent Developments
16.10. Perouse Medical
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financials
16.10.4. Application Benchmarking
16.10.5. Recent Developments
16.11. Glycar SA Pty Ltd
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financials
16.11.4. Application Benchmarking
16.11.5. Recent Developments
16.12. LabCor
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financials
16.12.4. Application Benchmarking
16.12.5. Recent Developments
16.13. Maverick Bioscience
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financials
16.13.4. Application Benchmarking
16.13.5. Recent Developments
16.14. Cryolife, Inc.
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financials
16.14.4. Application Benchmarking
16.14.5. Recent Developments
16.15. CorMatrix
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financials
16.15.4. Application Benchmarking
16.15.5. Recent Developments
16.16. Others Prominent Players

17. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Southern Lights Biomaterials
  • B. Braun
  • Baxter
  • Abbott
  • LeMaitre Vascular Inc.
  • Gunze Limited
  • Edwards Life Sciences Corporation
  • Atriummed
  • Perouse Medical
  • Glycar SA Pty Ltd.
  • LabCor
  • Maverick Bioscience
  • Cryolife Inc.
  • CorMatrix
  • Terumo Medical Corporation
  • Admedus
  • Bard Peripheral Vascular Inc.
  • Neovasc
  • W.L. Gore & Associates Inc.
  • Novomedics
  • TEI Biosciences Inc.
  • Integra LifeSciences Corporation